Persistent SARS-CoV-2 infection in SCID rats reflects immune vulnerability of the upper airway and trachea
6 affiliations
- 1Graduate School of Medicine, Tohoku University, Sendai, Japan
- 2National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan
- 3Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 4Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan
- 5Internatinal Research Institute of Disaster Science, Tohoku University, Sendai, Japan
- 6Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan
Abstract
In immunocompromised patients, persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries the risk of prolonged viral shedding and emergence of new variants. To reproduce the key features of persistent SARS-CoV-2 infection and evaluate its transmissibility, mouse-passaged SARS-CoV-2 was administered intranasally to severe combined immunodeficiency (SCID) rats deficient in Rag2 and Il2rg genes. The virus replicated in SCID rats for at least 6 weeks without causing severe symptoms. The main replication sites were the nasal cavity and trachea, and replicating viruses were barely detectable in the lungs. Infected areas within the nasal cavity and trachea showed minimal infiltration of neutrophils and M2 macrophages; however, a strong inflammatory response was observed in the lungs. Serial sequencing of the viral genome revealed accumulation of persistent mutations, predominantly in regions encoding nonstructural proteins. The persistently shed virus retained its infectivity, enabling its transmission to uninfected SCID rats. This model provides new insights into the immunological and tissue-associated features of persistent SARS-CoV-2 infection and offers a practical research platform for developing therapeutic interventions.
IMPORTANCE: Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised individuals promotes viral evolution and ongoing transmission, yet mechanistic studies have been limited by the absence of appropriate animal models. Existing mouse systems do not support longitudinal sampling or evaluate transmission, leaving critical questions unanswered. We established an SCID rat model that enables repeated noninvasive sampling from the same individuals, allowing longitudinal analysis of viral dynamics during prolonged infection. This approach revealed the emergence, disappearance, and fixation of viral mutations over time. Persistently infected rats also retained infectious and transmitted virus to naïve SCID rats, providing experimental evidence that prolonged infection preserves the transmission potential in this model. Persistent viral replication localized to the nasal cavity and trachea may be relevant to the upper-airway persistence reported in some immunocompromised patients. By capturing selected features of persistent SARS-CoV-2 infection under profoundly immunodeficient conditions, this model provides a valuable platform for investigating viral persistence, evolution, and transmission.
Related
- From respiratory viral infection to persistent cough hypersensitivity: neuroimmune regulation and therapeutic implications of P2X3/TRP ion-channel targets
- Self-Rated Health and Persistent Symptoms Among Adults Reporting Previous SARS-CoV-2 Infection: A Cross-Sectional Study
- Persistent Microfilaremia Caused by Dirofilaria asiatica Infection in 2-Year-Old Child, Sri Lanka, 2024
- The Tell-Tale Heart ― Persistent Immune Activation in Histologically Rejection-Free Heart Transplant Recipients ―
- Persistent HyperCKemia Beyond Post-Viral Myositis: A Case of Anti-HMGCR Immune-Mediated Necrotizing Myopathy
BibTeX
@article{miyazaki2026persistent,
title = {{Persistent SARS-CoV-2 infection in SCID rats reflects immune vulnerability of the upper airway and trachea}},
author = {Kaya Miyazaki and Nozomi Shiwa-Sudo and Naoko Iwata-Yoshikawa and Yusuke Sakai and Kazuto Yoshimi and Tomoji Mashimo and Tadaki Suzuki and Eiichi N. Kodama and Hideki Hasegawa and Noriyo Nagata},
journal = {Microbiology Spectrum},
year = {2026},
month = oct,
doi = {10.1128/spectrum.04105-25},
url = {https://doi.org/10.1128/spectrum.04105-25},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Persistent SARS-CoV-2 infection in SCID rats reflects immune vulnerability of the upper airway and trachea
AU - Kaya Miyazaki
AU - Nozomi Shiwa-Sudo
AU - Naoko Iwata-Yoshikawa
AU - Yusuke Sakai
AU - Kazuto Yoshimi
AU - Tomoji Mashimo
AU - Tadaki Suzuki
AU - Eiichi N. Kodama
AU - Hideki Hasegawa
AU - Noriyo Nagata
PY - 2026
DA - 2026/10/01
JO - Microbiology Spectrum
DO - 10.1128/spectrum.04105-25
UR - https://doi.org/10.1128/spectrum.04105-25
AB - In immunocompromised patients, persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries the risk of prolonged viral shedding and emergence of new variants. To reproduce the key features of persistent SARS-CoV-2 infection and evaluate its transmissibility, mouse-passaged SARS-CoV-2 was administered intranasally to severe combined immunodeficiency (SCID) rats deficient in Rag2 and Il2rg genes. The virus replicated in SCID rats for at least 6 weeks without causing severe symptoms. The main replication sites were the nasal cavity and trachea, and replicating viruses were barely detectable in the lungs. Infected areas within the nasal cavity and trachea showed minimal infiltration of neutrophils and M2 macrophages; however, a strong inflammatory response was observed in the lungs. Serial sequencing of the viral genome revealed accumulation of persistent mutations, predominantly in regions encoding nonstructural proteins. The persistently shed virus retained its infectivity, enabling its transmission to uninfected SCID rats. This model provides new insights into the immunological and tissue-associated features of persistent SARS-CoV-2 infection and offers a practical research platform for developing therapeutic interventions. IMPORTANCE: Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised individuals promotes viral evolution and ongoing transmission, yet mechanistic studies have been limited by the absence of appropriate animal models. Existing mouse systems do not support longitudinal sampling or evaluate transmission, leaving critical questions unanswered. We established an SCID rat model that enables repeated noninvasive sampling from the same individuals, allowing longitudinal analysis of viral dynamics during prolonged infection. This approach revealed the emergence, disappearance, and fixation of viral mutations over time. Persistently infected rats also retained infectious and transmitted virus to naïve SCID rats, providing experimental evidence that prolonged infection preserves the transmission potential in this model. Persistent viral replication localized to the nasal cavity and trachea may be relevant to the upper-airway persistence reported in some immunocompromised patients. By capturing selected features of persistent SARS-CoV-2 infection under profoundly immunodeficient conditions, this model provides a valuable platform for investigating viral persistence, evolution, and transmission.
SN - 2165-0497
ER -